Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Depreciation and Depletion (2016 - 2018)

Historic Depreciation and Depletion for Cytokinetics (CYTK) over the last 3 years, with Q4 2018 value amounting to -$359000.0.

  • Cytokinetics' Depreciation and Depletion fell 16084.75% to -$359000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $1.2 million, marking a year-over-year decrease of 3684.21%. This contributed to the annual value of $9.5 million for FY2024, which is 2016.81% down from last year.
  • Latest data reveals that Cytokinetics reported Depreciation and Depletion of -$359000.0 as of Q4 2018, which was down 16084.75% from $268000.0 recorded in Q3 2018.
  • Cytokinetics' 5-year Depreciation and Depletion high stood at $673000.0 for Q1 2018, and its period low was -$359000.0 during Q4 2018.
  • For the 3-year period, Cytokinetics' Depreciation and Depletion averaged around $364777.8, with its median value being $439000.0 (2017).
  • In the last 5 years, Cytokinetics' Depreciation and Depletion surged by 22240.44% in 2017 and then crashed by 16084.75% in 2018.
  • Quarter analysis of 3 years shows Cytokinetics' Depreciation and Depletion stood at $183000.0 in 2016, then skyrocketed by 222.4% to $590000.0 in 2017, then tumbled by 160.85% to -$359000.0 in 2018.
  • Its Depreciation and Depletion was -$359000.0 in Q4 2018, compared to $268000.0 in Q3 2018 and $618000.0 in Q2 2018.